NEW YORK, Safar 9, 1437, Nov 21, 2015, SPA -- The U.S. Food and Drug Administration on Friday approved a third drug to treat multiple myeloma, a type of blood cancer, according to AP. The approved drug, called Ninlaro, is made by Japan's Takeda Pharmaceutical Co. The FDA approved two other multiple myeloma treatments this year, one from Johnson & Johnson and the other from Novartis AG. The National Cancer Institute estimates that about 27,000 people will be diagnosed with multiple myeloma this year and more than 11,200 people will die of the disease. -- SPA 00:45 LOCAL TIME 21:45 GMT www.spa.gov.sa/w